Prevalence, clinical and molecular characteristics of early stage EGFR-mutated lung cancer in a real-life West-European cohort: Implications for adjuvant therapy

Liesbeth M. Hondelink, Sophie M. Ernst, Peggy Atmodimedjo, Danielle Cohen, Janina L. Wolf, Anne Marie C. Dingemans, Hendrikus J. Dubbink, Jan H. von der Thüsen*

*Corresponding author for this work

Research output: Contribution to journal › Article › Academic › peer-review

12 Citations (Scopus)
174 Downloads (Pure)

Fingerprint

Dive into the research topics of 'Prevalence, clinical and molecular characteristics of early stage EGFR-mutated lung cancer in a real-life West-European cohort: Implications for adjuvant therapy'. Together they form a unique fingerprint.

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science

Biochemistry, Genetics and Molecular Biology